ENSP has launched the second Series of Fact Sheets covering a range of tobacco control topics. The latest 3 editions are dedicated to Tobacco Taxation, Emerging and Novel Tobacco Products and Impact of novel and emerging products AND youth.
Context: the tobacco epidemic in Europe
High prevalence: Compared to the rest of the world, the WHO Europe Region has the highest prevalence of tobacco smoking adults and among the highest smoking rates among adolescents.
High costs: Direct health costs: Tobacco-related disease
Indirect costs: Premature death, disability due to disease, decreased productivity
High morbidity and mortality: Tobacco use is estimated to be responsible for 16% of all deaths in adults above the age of 30 in the WHO Europe Region and a major contributor to socioeconomic disparity.
What are ‘novel tobacco products’?
According to the EU Tobacco Products Directive (2014/40/EU), a ‘novel tobacco product’ is defined as a tobacco product which does not fall into any of the following categories: cigarettes, roll-you-own tobacco, pipe tobacco, waterpipe tobacco, cigars, cigarillos, chewing tobacco, nasal tobacco or tobacco for oral use ; and was placed on the market after 19 May 2014.
Context: Secondhand Aerosol (SHA)
CONTEST DETAILS 1. PARTICIPATE We are happy to invite young individuals, members of youth and student associations and youth advocacy groups from the WHO European region to participate in...
Due to ongoing uncertainty surrounding the coronavirus pandemic and the disruption to travel and social gatherings into 2020, the ENSP Board has decided to suspend the 5th ENSP-ECTC Conference, that...
The webinar, titled #TobaccoExposed: protecting youth from deceptive tobacco industry marketing will focus on this year’s WNTD theme and highlight the importance of protecting youth from tobacco industry manipulation....